Free shipping on all orders over $ 500

 About 6 results found for searched term "Adenosine receptor inhibitor 1" (0.135 seconds)

Cat.No.  Name Target
M40664 Adenosine receptor inhibitor 1 Adenosine Receptor
Adenosine receptor inhibitor 1 is a potent, selective adenosine receptor inhibitor with Ki values of >1000, 68.5, >1000, >1000, >1000 nM for A1AR, A2AAR, A2BAR, and A3AR, respectively, and possesses analgesic as well as anti-inflammatory activity. It has analgesic and anti-inflammatory activities and can be used in cancer and neurodegenerative disease research.
M7531 AZD4635 Adenosine Receptor
HTL1071
AZD4635 is a novel adenosine 2A receptor (A2AR) inhibitor with a Ki of 1.7 nM.
M7713 2-Chloroadenosine Adenosine Receptor
2-Chloroadenosine is a selective A1 adenosine receptor agonist. 2-Chloroadenosine is an apparent competitive inhibitor of uridine influx (apparent Ki=33 μM) and high-affinity nitrobenzylthioinosine binding (apparent Ki=0.18 mM).
M30970 N-[(4-Aminophenyl)methyl]adenosine Adenosine Receptor
N-[(4-Aminophenyl)methyl]adenosine is a adenosine receptor inhibitor, with Ki of 29 nM for Rat ecto-5′-Nucleotidase. IC50 value: 29.0 ± 1.7 nM (Ki) Target: Adenosine Receptor
M40659 hA2A/hCA XII modulator 1 Adenosine Receptor
hA2A/hCA XII modulator 1 is a triazolopyrazine and a potent adenosine receptor hA2A antagonist, with Ki of 6.4 nM, 4.819 μM, and >30 μM for hA2AAR, hA1AR, and hA3AR, respectively. hA2A/hCA XII modulator 1 is a potent inhibitor of human carbonic anhydrase XII (hCA XII). In addition, hA2A/hCA XII modulator 1 is also a potent human carbonic anhydrase XII (hCA XII) inhibitor with Ki of 6.2 nM, 46 nM, 466 nM, 8.351 μM for hCA XII, hCA II, hCA IX, and hCA I, respectively, and can be used in cancer-related studies.
M40661 Adenosine receptor inhibitor 2 Adenosine Receptor
Adenosine receptor inhibitor 2 is a potent adenosine receptor AR inhibitor with dual affinity for A1/A2A ARs with Ki values of 52.2 and 167 nM, respectively.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.